Erling Falk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erling Falk has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Troels Thim
Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
4 shared publications - William P. Paaske
Department Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark
3 shared publications - Henrik Sillesen
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
2 shared publications - Samuel A. Thrysøe
MR-center, Aarhus University Hospital Skejby, Brendstrupsgaardsvej 100, Aarhus N DK-8200, Denmark
2 shared publications - Steen Fjord Pedersen
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark
2 shared publications - Steffen Ringgaard
The MR Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
2 shared publications
Latest Publications
- Top Cited Papers
- 6 June 2014
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 114 (12) , 1852-1866
Mechanisms of Plaque Formation and Rupture
Atherosclerosis causes clinical disease through luminal narrowing or by precipitating thrombi that obstruct blood flow to the heart (coronary heart disease), brain (ischemic stroke), or lower extremities (peripheral vascular disease). The most common of these manifestations is coronary heart disease, including stable angina pectoris and the acute coronary syndromes. Atherosclerosis is a lipoprotein-driven disease that leads to plaque formation at specific sites of the arterial tree through intimal inflammation, necrosis, fibrosis, and calcification. After decades of indolent progression, such plaques may suddenly cause life-threatening coronary thrombosis presenting as an acute coronary syndrome. Most often, the culprit morphology is plaque rupture with exposure of highly thrombogenic, red cell–rich necrotic core material. The permissive structural requirement for this to occur is an extremely thin fibrous cap, and thus, ruptures occur mainly among lesions defined as thin-cap fibroatheromas. Also common are thrombi forming on lesions without rupture (plaque erosion), most often on pathological intimal thickening or fibroatheromas. However, the mechanisms involved in plaque erosion remain largely unknown, although coronary spasm is suspected. The calcified nodule has been suggested as a rare cause of coronary thrombosis in highly calcified and tortious arteries in older individuals. To characterize the severity and prognosis of plaques, several terms are used. Plaque burden denotes the extent of disease, whereas plaque activity is an ambiguous term, which may refer to one of several processes that characterize progression. Plaque vulnerability describes the short-term risk of precipitating symptomatic thrombosis. In this review, we discuss mechanisms of atherosclerotic plaque initiation and progression; how plaques suddenly precipitate life-threatening thrombi; and the concepts of plaque burden, activity, and vulnerability.
- 6 June 2014
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 114 (12) , 1852-1866
Top Cited PapersMechanisms of Plaque Formation and Rupture
Atherosclerosis causes clinical disease through luminal narrowing or by precipitating thrombi that obstruct blood flow to the heart (coronary heart disease), brain (ischemic stroke), or lower extremities (peripheral vascular disease). The most common of these manifestations is coronary heart disease, including stable angina pectoris and the acute coronary syndromes. Atherosclerosis is a lipoprotein-driven disease that leads to plaque formation at specific sites of the arterial tree through intimal inflammation, necrosis, fibrosis, and calcification. After decades of indolent progression, such plaques may suddenly cause life-threatening coronary thrombosis presenting as an acute coronary syndrome. Most often, the culprit morphology is plaque rupture with exposure of highly thrombogenic, red cell–rich necrotic core material. The permissive structural requirement for this to occur is an extremely thin fibrous cap, and thus, ruptures occur mainly among lesions defined as thin-cap fibroatheromas. Also common are thrombi forming on lesions without rupture (plaque erosion), most often on pathological intimal thickening or fibroatheromas. However, the mechanisms involved in plaque erosion remain largely unknown, although coronary spasm is suspected. The calcified nodule has been suggested as a rare cause of coronary thrombosis in highly calcified and tortious arteries in older individuals. To characterize the severity and prognosis of plaques, several terms are used. Plaque burden denotes the extent of disease, whereas plaque activity is an ambiguous term, which may refer to one of several processes that characterize progression. Plaque vulnerability describes the short-term risk of precipitating symptomatic thrombosis. In this review, we discuss mechanisms of atherosclerotic plaque initiation and progression; how plaques suddenly precipitate life-threatening thrombi; and the concepts of plaque burden, activity, and vulnerability.
- Open Access
- 31 March 2012
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 12 (1) , 24
Oversized vein grafts develop advanced atherosclerosis in hypercholesterolemic minipigs
Accelerated atherosclerosis is the main cause of late aortocoronary vein graft failure. We aimed to develop a large animal model for the study of pathogenesis and treatment of vein graft atherosclerosis.
- 31 March 2012
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 12 (1) , 24
Open AccessOversized vein grafts develop advanced atherosclerosis in hypercholesterolemic minipigs
Accelerated atherosclerosis is the main cause of late aortocoronary vein graft failure. We aimed to develop a large animal model for the study of pathogenesis and treatment of vein graft atherosclerosis.
- Open Access
- 22 March 2012
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 10 (1) , 12
Spatial orientation of cross-sectional images of coronary arteries: point of view in intracoronary imaging
In studies where cross-sectional images of coronary arteries obtained with different imaging modalities are compared, the importance of correct co-localization and matching of images along the coronary artery longitudinal axis is obvious. However, it appears neglected that correct spatial orientation of the cross-sectional plane may not be obtainable just by rotating the images to ensure co-localization of identifiable landmarks such as sidebranches. A cross-section has two sides, one facing proximally and the other distally, and pairs of images reconstructed corresponding to these opposite points of view are mirror images of each other and not superimposable. This may be difficult if not impossible to recognize and unrecognized it will give rise to flawed results in the development and validation of imaging technologies aimed at plaque characterization (tissue mapping). We determined the imagined point of view for three commercially available intracoronary imaging systems used by invasive cardiologists and illustrate its importance in imaging modality validation.
- 22 March 2012
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 10 (1) , 12
Open AccessSpatial orientation of cross-sectional images of coronary arteries: point of view in intracoronary imaging
In studies where cross-sectional images of coronary arteries obtained with different imaging modalities are compared, the importance of correct co-localization and matching of images along the coronary artery longitudinal axis is obvious. However, it appears neglected that correct spatial orientation of the cross-sectional plane may not be obtainable just by rotating the images to ensure co-localization of identifiable landmarks such as sidebranches. A cross-section has two sides, one facing proximally and the other distally, and pairs of images reconstructed corresponding to these opposite points of view are mirror images of each other and not superimposable. This may be difficult if not impossible to recognize and unrecognized it will give rise to flawed results in the development and validation of imaging technologies aimed at plaque characterization (tissue mapping). We determined the imagined point of view for three commercially available intracoronary imaging systems used by invasive cardiologists and illustrate its importance in imaging modality validation.
- 3 August 2011
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 13 (5) , 345-352
The SHAPE Guideline: Ahead of Its Time or Just in Time?
In 2006, a grass roots movement called SHAPE (Screening for Heart Attack Prevention and Education) published a novel practice guideline for cardiovascular screening in the asymptomatic at-risk population. It suggested the use of noninvasive tests for subclinical atherosclerosis in cardiovascular risk assessment to target intensified preventive care to those at highest risk. The SHAPE guideline received much attention but not as much support from the “official” medical societies. However, subsequent studies published since 2006 have now provided strong supportive evidence for the strategy spearheaded by the SHAPE guideline. Indeed, the latest guidelines issued jointly by the American Heart Association and the American College of Cardiology have elevated recommendation levels for noninvasive imaging of subclinical atherosclerosis. This change is widely viewed as a significant step toward the SHAPE guidelines. The background for SHAPE and the evidence behind the recommendation to use coronary artery calcium score measured by computed tomography, carotid intima-media thickness and plaque measured by ultrasound, and ankle-brachial index in cardiovascular risk assessment is reviewed in this article.
- 3 August 2011
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 13 (5) , 345-352
The SHAPE Guideline: Ahead of Its Time or Just in Time?
In 2006, a grass roots movement called SHAPE (Screening for Heart Attack Prevention and Education) published a novel practice guideline for cardiovascular screening in the asymptomatic at-risk population. It suggested the use of noninvasive tests for subclinical atherosclerosis in cardiovascular risk assessment to target intensified preventive care to those at highest risk. The SHAPE guideline received much attention but not as much support from the “official” medical societies. However, subsequent studies published since 2006 have now provided strong supportive evidence for the strategy spearheaded by the SHAPE guideline. Indeed, the latest guidelines issued jointly by the American Heart Association and the American College of Cardiology have elevated recommendation levels for noninvasive imaging of subclinical atherosclerosis. This change is widely viewed as a significant step toward the SHAPE guidelines. The background for SHAPE and the evidence behind the recommendation to use coronary artery calcium score measured by computed tomography, carotid intima-media thickness and plaque measured by ultrasound, and ankle-brachial index in cardiovascular risk assessment is reviewed in this article.
- Open Access
- 29 July 2011
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 13 (5) , 359-366
The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population
The High-Risk Plaque (HRP) Initiative is a research and development effort to advance the understanding, recognition, and management of asymptomatic individuals at risk for a near-term atherothrombotic event such as myocardial infarction or stroke. Clinical studies using the newest technologies have been initiated, including the BioImage Study in which novel approaches are tested in a typical health plan population. Asymptomatic at-risk individuals were enrolled, including a survey-only group (n = 865), a group undergoing traditional risk factor scoring (n = 718), and a group in which all were assessed for both risk factors and subclinical atherosclerosis (n = 6104). The latter two groups underwent baseline examination in a dedicated mobile facility equipped with advanced imaging tools suitable for noninvasive screening for subclinical atherosclerosis (coronary artery calcium by computed tomography [CT], carotid and aortic disease by ultrasound, and ankle-brachial index). Selected participants were offered advanced imaging (contrast-enhanced CT, magnetic resonance imaging, and positron emission tomography/CT). Plasma, PAXgene RNA, and DNA samples were obtained for biomarker discovery studies. All individuals will be followed until 600 major atherothrombotic events have occurred in those undergoing imaging.
- 29 July 2011
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 13 (5) , 359-366
Open AccessThe High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population
The High-Risk Plaque (HRP) Initiative is a research and development effort to advance the understanding, recognition, and management of asymptomatic individuals at risk for a near-term atherothrombotic event such as myocardial infarction or stroke. Clinical studies using the newest technologies have been initiated, including the BioImage Study in which novel approaches are tested in a typical health plan population. Asymptomatic at-risk individuals were enrolled, including a survey-only group (n = 865), a group undergoing traditional risk factor scoring (n = 718), and a group in which all were assessed for both risk factors and subclinical atherosclerosis (n = 6104). The latter two groups underwent baseline examination in a dedicated mobile facility equipped with advanced imaging tools suitable for noninvasive screening for subclinical atherosclerosis (coronary artery calcium by computed tomography [CT], carotid and aortic disease by ultrasound, and ankle-brachial index). Selected participants were offered advanced imaging (contrast-enhanced CT, magnetic resonance imaging, and positron emission tomography/CT). Plasma, PAXgene RNA, and DNA samples were obtained for biomarker discovery studies. All individuals will be followed until 600 major atherothrombotic events have occurred in those undergoing imaging.
- Open Access
- 1 January 2011
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 13 (1) , 52
Determination of Edema in Porcine Coronary Arteries by T2 Weighted Cardiovascular Magnetic Resonance
- 1 January 2011
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 13 (1) , 52
Open AccessDetermination of Edema in Porcine Coronary Arteries by T2 Weighted Cardiovascular Magnetic Resonance
- Open Access
- 1 January 2011
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 13 (1) , 10
CMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset
- 1 January 2011
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 13 (1) , 10
Open AccessCMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset
- 19 April 2010
- Vol. 172 (16) , 1236
[Calcinosis screening in asymptomatic persons].
- 1 January 2007
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (1) , 248-249
Neointimal Cracks (Plaque Rupture?) and Thrombosis in Wrapped Arteries Without Flow
- 1 January 2007
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (1) , 248-249
Neointimal Cracks (Plaque Rupture?) and Thrombosis in Wrapped Arteries Without Flow
- Top Cited Papers
Pathogenesis of Atherosclerosis